Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Dec;61(6):964-7.
doi: 10.4269/ajtmh.1999.61.964.

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine

Affiliations
Clinical Trial

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine

M van Vugt et al. Am J Trop Med Hyg. 1999 Dec.

Abstract

Artemether-lumefantrine is a new fixed antimalarial combination effective against multidrug-resistant falciparum malaria. A prospective electrocardiographic study was conducted in 150 patients receiving artemetherlumefantrine and 50 treated with artesunate-mefloquine. There was no evidence for clinically significant changes in the electrocardiographic intervals and in particular no relationship between plasma concentrations of lumefantrine and QTc prolongation. Artemether-lumefantrine does not have significant cardiac effects at therapeutic doses.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources